Bronchoobstructive syndrome in modern therapeutic practice
- Authors: Babak S.L.1, Gorbunova M.V.2, Malyavin A.G.2
-
Affiliations:
- A.I. Yevdokimov Moscow State University of medicine and dentistr
- A.I. Yevdokimov Moscow State University of medicine and dentistry
- Issue: No 1 (2017)
- Pages: 47-53
- Section: Articles
- URL: https://journals.eco-vector.com/2412-4036/article/view/277609
- ID: 277609
Cite item
Open Access
Access granted
Abstract
Bronchoobstructive syndrome (BOS) is a collective term that includes a number of symptoms of clinical manifestations of bronchial obstruction with underlying narrowing or occlusion of the airway. Clinically severe bronchoobstructive syndrome is most common in children, especially young children, but it is not a rare disease among the adult population. Its emergence and development is influenced by various factors, primarily respiratory viral infection. Early diagnosis and treatment of BOS in a therapeutic practice can significantly reduce the number of complications of the disease, improve survival and quality of life of patients.
Full Text
About the authors
Sergey L. Babak
A.I. Yevdokimov Moscow State University of medicine and dentistr
Email: sergbabak@mail.ru
MD, professor, Department of phthisiology and pulmonology
Marina V. Gorbunova
A.I. Yevdokimov Moscow State University of medicine and dentistry
Email: mgorb@mail.ru
PhD, associated professor, Department of phthisiology and pulmonology
Andrey G. Malyavin
A.I. Yevdokimov Moscow State University of medicine and dentistry
Email: maliavin@mail.ru
MD, professor, Department of phthisiology and pulmonology
References
- Гавалов С.М. Синдром гиперреактивности бронхов и его клинические разновидности. Consilium medicum. 1999;1:3-11. [Gavalov S.M. Syndrome of bronchial hyperresponsiveness and its clinical varieties. Consilium medicum. 1999;1:3-11 (in Russ.)]
- Кун Т. Структура научных революций. М.: Прогресс, 1977:69-71. [Kun T. Structure of science revolutions. M.: Progress, 1977:69-71 (in Russ.)]
- Han M.K., Agusti A., Calverley P.M., Celli B.R., Criner G., Curtis J.L., Fabbri L.M., Goldin J.G., Jones P.W., Macnee W., Make B.J., Rabe K.F., Rennard S.I., Sciurba F.C., Silverman E.K., Vestbo J., Washko G.R., Wouters E.F., Martinez F.J. Chronic obstructive pulmonary disease phenotypes: the future of COPD. Am. J. Respir. Crit. Care. Med. 2010;182(5):598-604.
- The writings of Benjamin Franklin. Collected and edited with a life and introduction by Albert Henry. London: Macmillan & Co., LTD., 1906;6:676, 1773-6.
- Davidson T., Odle T.G. Common Cold. Gale encyclopedia of medicine. Detroit: Gale. 2006;2:955-9.
- Braman S.S. Postinfectious cough: ACCP evidence-based clinical practice guidelines. Chest. 2006;129 (Suppl. 1):138S-146S.
- Braman S.S. Chronic cough due to acute bronchitis: ACCP evidence-based clinical practice guidelines. Chest. 2006; 129 (Suppl. 1):95S-103S.
- Goldsobel A.B., Chipps B.E. Cough in the pediatric population. J. Pediatr. 2010;156(3):352-8.
- Irwin R.S., Baumann M.H., Bolser D.C., Boulet L.P., Braman S.S., Brightling C.E., Brown K.K., Canning B.J., Chang A.B., Dicpinigaitis P.V., Eccles R., Glomb W.B., Goldstein L.B., Graham L.M., Hargreave F.E., Kvale P.A., Lewis S.Z., McCool F.D., McCrory D.C., Prakash U.B., Pratter M.R., Rosen M.J., Schulman E., Shannon J.J., Smith Hammond C., Tarlo S.M. American College of Chest Physicians (ACCP). Diagnosis and management of cough executive summary: ACCP evidence-based clinical practice guidelines. Chest. 2006;129 (Suppl. 1):1S-23S.
- Tse S., Tantisira K., Weiss S. The pharmacogenetics and pharmacogenomics of asthma therapy. Pharmacogenomics J. 2011;11(6):383-92.
- Шмелев Е.И. Бронхообструктивный синдром - универсальный синдром при болезнях органов дыхания. Доктор.ру. 2007;2(33): 32-6. [Shmelev Ye.I. Bronchial obstructive syndrome is a universal syndrome in diseases of the respiratory system. Doctor.ru. 2007;2(33):32-6 (in Russ.)]
- Скачилова С.Я., Терешкина О.И., Шилова Е.В., Рудакова И.П., Балаев Т.А., Соловьев А.Ю., Молостова Т.Н., Самылина И.А. Особенности лекарственных форм для ингаляций, применяемых в пульмонологии. Фармация. 2016;65(3):51-60. [Skachilova S.Ya., Tereshkina O.I., Shilova Ye.V., Rudakov I.P., Balaev T.A., Soloviev A.Yu., Molostova T.N., Samylina I.A. Peculiarities of medicinal forms for inhalation used in pulmonology. Pharmacy. 2016;65(3):51-60 (in Russ.)]
- Holland A., Smith F., Penny K., McCrossan G., Veitch L., Nicholson C. Metered dose inhalers versus nebulizers for aerosol bronchodilator delivery for adult patients receiving mechanical ventilation in critical care units. Cochrane Database Syst. Rev. 2013;6:CD008863.
- Авдеев С.Н., Бродская О.Н. Стери-Небы - новые возможности небулайзерной терапии обструктивных заболеваний легких. Научное обозрение респираторной медицины. 2011;3:18-23. [Avdeev S.N., Brodskaya O.N. Sterile-Nebs - new opportunities of nebulizer therapy of obstructive pulmonary disease. Scientific review of respiratory medicine. 2011;3:18-23 (in Russ.)]
- Weber E.J., Levitt M.A., Covington J.K., Gambrioli E. Effect of continuously nebulized ipratropium bromide plus albuterol on emergency department length of stay and hospital admission rates in patients with acute bronchospasm. A randomized controlled trial. Chest. 1999;115(4):937-44.
- Зырянов С.К., Галеева Ж.А., Белоусов Ю.Б. Качественные генерики для лечения бронхообструктивных заболеваний: свет в конце тоннеля есть! Лечащий врач. 2014;11:72. [Zyryanov S.K., Galeev J.A., Belousov Yu.B. High-quality generics for the treatment of bronchoobstructive diseases: there is light at the end of the tunnel! Doctor. 2014;11:72 (in Russ.)]
Supplementary files
